North America Addictions Therapeutics Market Developments and Forecast by 2027

Historic Data: 2017-2018   |   Base Year: 2019   |   Forecast Period: 2020-2027

North America Addictions Therapeutics Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Treatment Type (Nicotine Addiction Treatment, Alcohol Addiction Treatment, Opioid Addiction Treatment, Other Substance Addiction Treatment); Drug Type (Varenicline, Bupropion, Nicotine Replacement Products, Buprenorphine, Naltrexone, Disulfiram, Others); Treatment Center (Outpatient Treatment Center, Residential Treatment Center, Inpatient Treatment Center); Distribution Channel (Hospitals, Medical Stores, Others) and Country

  • Report Date : Dec 2020
  • Report Code : TIPRE00017280
  • Category : Life Sciences
  • Status : Published
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 94

The North America Addictions Therapeutics market is expected to reach US$ 6,102.31 million by 2027 from US$ 3,715.23 million in 2019. The market is estimated to grow with a CAGR of 6.5% from 2020 to 2027.

The growth of the market is attributed to rising approval of new drugs and launch of digital therapeutics to treat addiction, conduction of various awareness campaigns and government efforts to counteract drug abuse and promote medication. However, high cost associated with drug development is hindering the growth of the addiction therapeutics market.

Drug addiction, also referred to as substance disorder, is a type of disease that hampers an individual’s brain, behavior, and metabolic processes leading to an inability to control. Non-medical use and abuse of prescription drugs are becoming severe issues worldwide. Addiction to abusive substances is responsible for the death of millions of people across the world. According to the National Institute on Drug Abuse (NIDA) estimates, ~21 million people across the world had at least one addiction in 2019, out of which only 10% received treatment for the same. The Addiction Center reports state that the number of people undertaking treatments for addictions has increased in recent years. Thus, the rising awareness among people about drug addiction treatment is likely to support the growth of the North America addiction therapeutics market in the coming years. Similarly, awareness campaigns and government efforts to counteract drug abuse and promote medication for all sorts of addiction treatments would fuel the market growth during the forecast period.

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

North America Addictions Therapeutics Market: Strategic Insights

north-america-addictions-therapeutics-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

The COVID-19 pandemic is hindering the North America addictions therapeutics market. Due to the outbreak of disease, healthcare industries have been affected severely, considering the economic conditions in the current situation. Moreover, the traditional difficulties regarding treatment access and adherence for the population suffering from addictions will worsen during the pandemic, therefore aggravating their condition.

North America Addictions Therapeutics Market Regional Insights

The regional trends and factors influencing the North America Addictions Therapeutics Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses North America Addictions Therapeutics Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

north-america-addictions-therapeutics-market-global-geography
  • Get the Regional Specific Data for North America Addictions Therapeutics Market

North America Addictions Therapeutics Market Report Scope

Report Attribute Details
Market size in 2019 US$ 3,715.23 Million
Market Size by 2027 US$ 6,102.31 Million
Global CAGR (2020 - 2027) 6.5%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By Treatment Type
  • Nicotine Addiction Treatment
  • Alcohol Addiction Treatment
  • Opioid Addiction Treatment
  • Other Substance Addiction Treatment
By Drug Type
  • Varenicline
  • Bupropion
  • Nicotine Replacement Products
  • Buprenorphine
  • Naltrexone
  • Disulfiram
By Treatment Center
  • Outpatient Treatment Center
  • Residential Treatment Center
  • Inpatient Treatment Center
By Distribution Channel
  • Hospitals
  • Medical Stores
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Market leaders and key company profiles
  • Indivior PLC
  • Pfizer Inc
  • GlaxoSmithKline plc
  • Bausch Health Companies Inc
  • Cipla Inc.
  • Orexo AB
  • Purdue Pharma L.P
  • Alvogen
  • Camurus AB

  • North America Addictions Therapeutics Market Players Density: Understanding Its Impact on Business Dynamics

    The North America Addictions Therapeutics Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

    Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

    Major Companies operating in the North America Addictions Therapeutics Market are:

    1. Indivior PLC
    2. Pfizer Inc
    3. GlaxoSmithKline plc
    4. Bausch Health Companies Inc
    5. Cipla Inc.

    Disclaimer: The companies listed above are not ranked in any particular order.


    north-america-addictions-therapeutics-market-cagr

    • Get the North America Addictions Therapeutics Market top key players overview

    North America Addictions Therapeutics Market Segmentation

    By Treatment Type

    • Opioid Addiction Treatment
    • Alcohol Addiction Treatment
    • Nicotine Addiction Treatment
    • Other Substance Addiction Treatment

    By Drug Type

    • Buprenorphine
    • Naltrexone
    • Bupropion
    • Disulfiram
    • Nicotine Replacement Products
    • Varenicline
    • Others

    By Treatment Center

    • Inpatient Treatment Center
    • Residential Treatment Center
    • Outpatient Treatment Center

    By Distribution Channel

    • Hospital Pharmacies
    • Medical stores
    • Others

    By Country

    • United States
    • Canada
    • Mexico

    Company Profiles

    • Indivior PLC
    • Pfizer Inc
    • GlaxoSmithKline plc
    • Bausch Health Companies Inc
    • Cipla Inc.
    • Orexo AB
    • Purdue Pharma L.P
    • Alvogen
    • Camurus AB
    • Hikma Pharmaceuticals PLC
    Mrinal Kerhalkar
    Mrinal Kerhalkar
    Manager,
    Market Research & Consulting

    Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

    Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset

    Testimonials

    Reason to Buy

    • Informed Decision-Making
    • Understanding Market Dynamics
    • Competitive Analysis
    • Identifying Emerging Markets
    • Customer Insights
    • Market Forecasts
    • Risk Mitigation
    • Boosting Operational Efficiency
    • Strategic Planning
    • Investment Justification
    • Tracking Industry Innovations
    • Aligning with Regulatory Trends
    Your Key Concerns Addressed - Question & Answer
    Can I view a sample of the report before purchasing?

    Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

    Is analyst support included with the purchase?

    Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

    What are the next steps once I place an order?

    Once your order is successfully placed, you will receive a confirmation email along with your invoice.

    • For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
    • For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

    Can the report be tailored to suit my specific needs?

    We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.

    In what format is the report delivered?

    The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

    The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
    Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

    How secure is the payment process on your platform?

    Our payment process is fully secure and PCI-DSS compliant.

    We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
    You can make your purchase with confidence, knowing your personal and financial information is safe with us.

    Do you provide special pricing for buying multiple reports?

    Yes, we do offer special pricing for bulk purchases.
    If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.

    Can I connect with your team to discuss the report before buying?

    Yes, absolutely.
    Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

    Will I get a billing invoice upon purchase?

    Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
    If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.

    Is there support available if I can’t access my report?

    Yes, certainly.
    If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.

    Our Clients
    • Indivior PLC
    • Pfizer Inc
    • GlaxoSmithKline plc
    • Bausch Health Companies Inc
    • Cipla Inc.
    • Orexo AB
    • Purdue Pharma L.P
    • Alvogen
    • Camurus AB
    • Hikma Pharmaceuticals PLC
    Sales Assistance
    US: +1-646-491-9876
    UK: +44-20-8125-4005
    Email: sales@theinsightpartners.com
    Chat with us
    DUNS Logo
    87-673-9708
    ISO Certified Logo
    ISO 9001:2015
    ISO Certified Logo